Share

June 2015; 2 (3) Clinical/Scientific NotesOpen Access

Aquaporin-4–positive myelitis associated with Sjögren syndrome and colonic adenocarcinoma

Thomas Rossel, Anastasia Zekeridou, Francois Ochsner, Susanne Renaud
First published April 9, 2015, DOI: https://doi.org/10.1212/NXI.0000000000000103
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
519

Share

Article Information

vol. 2 no. 3 e103
DOI: 
https://doi.org/10.1212/NXI.0000000000000103
PubMed: 
25884013
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2332-7812
History: 
  • Received January 8, 2015
  • Accepted in final form March 9, 2015
  • First Published April 9, 2015.
Copyright & Usage: 
© 2015 American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-Noncommercial No Derivative 3.0 License, which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.

Author Disclosures

    1. Thomas Rossel, MD,
    2. Anastasia Zekeridou, MD,
    3. Francois Ochsner, MD and
    4. Susanne Renaud, MD
  1. Thomas Rossel, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Anastasia Zekeridou, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Francois Ochsner, MD and
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Susanne Renaud, MD
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Division of Neurology (T.R., A.Z., S.R.), Pourtalès Hospital, Neuchatel, Switzerland; and Department of Clinical Neurosciences (F.O.), University Hospital of Lausanne, Switzerland.
  1. Correspondence to Dr. Zekeridou: anastasia.zek{at}gmail.com
View Full Text

Article usage

Article usage: April 2015 to December 2022

AbstractFullPdfSource
Apr 2015581419Highwire
Apr 20150176pmc
May 20154276Highwire
May 201503113pmc
Jun 201512416427Highwire
Jun 20150163pmc
Jul 201531276Highwire
Jul 20150123pmc
Aug 20153973Highwire
Aug 20150114pmc
Sep 201513103Highwire
Sep 20150146pmc
Oct 201516102Highwire
Oct 20150131pmc
Nov 201510108Highwire
Nov 20150165pmc
Dec 2015440Highwire
Dec 20150155pmc
Jan 201618143Highwire
Jan 2016054pmc
Feb 2016773Highwire
Feb 2016055pmc
Mar 20161032Highwire
Mar 2016083pmc
Apr 2016350Highwire
Apr 2016070pmc
May 2016640Highwire
May 2016041pmc
Jun 20162114Highwire
Jun 2016060pmc
Jul 20161421Highwire
Jul 2016053pmc
Aug 20162244Highwire
Aug 2016040pmc
Sep 20161110Highwire
Sep 20160115pmc
Oct 20161021Highwire
Oct 20160103pmc
Nov 2016923Highwire
Nov 20160102pmc
Dec 2016500Highwire
Dec 20160103pmc
Jan 2017711Highwire
Jan 2017071pmc
Feb 2017521Highwire
Feb 2017082pmc
Mar 2017852Highwire
Mar 2017061pmc
Apr 2017422Highwire
Apr 20173910pmc
May 2017520Highwire
May 201711212pmc
Jun 2017231Highwire
Jun 201701213pmc
Jul 2017010Highwire
Jul 2017166pmc
Aug 2017491Highwire
Aug 20171109pmc
Sep 2017200Highwire
Sep 201741212pmc
Oct 2017500Highwire
Oct 201721312pmc
Nov 2017511Highwire
Nov 201711010pmc
Dec 2017353Highwire
Jan 2018130Highwire
Feb 2018153Highwire
Mar 2018083Highwire
Apr 20181172Highwire
Apr 2018278pmc
May 20180132Highwire
Jun 20181212Highwire
Jun 2018145pmc
Jul 20183205Highwire
Aug 20181191Highwire
Aug 2018265pmc
Sep 2018061Highwire
Oct 20180141Highwire
Nov 20182220Highwire
Dec 20180161Highwire
Jan 20193131Highwire
Feb 20191151Highwire
Mar 20192244Highwire
Apr 2019474Highwire
May 2019393Highwire
Jun 2019481Highwire
Jul 2019456Highwire
Aug 2019284Highwire
Sep 2019374Highwire
Oct 20191101Highwire
Nov 2019273Highwire
Dec 2019223Highwire
Jan 20201103Highwire
Feb 2020271Highwire
Mar 2020085Highwire
Apr 2020010Highwire
May 2020151Highwire
Jun 2020056Highwire
Jul 2020062Highwire
Aug 2020051Highwire
Sep 20202113Highwire
Oct 20200245Highwire
Nov 2020053Highwire
Dec 2020296Highwire
Jan 20211123Highwire
Feb 2021457Highwire
Mar 2021740Highwire
Apr 2021281Highwire
May 20210101Highwire
Jun 20214103Highwire
Jul 20211510Highwire
Aug 20212161Highwire
Sep 2021268Highwire
Oct 202121021Highwire
Nov 202101017Highwire
Dec 20210186Highwire
Jan 2022283Highwire
Feb 2022051Highwire
Mar 20220140Highwire
Apr 20222101Highwire
May 2022299Highwire
Jun 20221102Highwire
Jul 2022392Highwire
Aug 20220192Highwire
Sep 202212410Highwire
Oct 20221238Highwire
Nov 202204816Highwire
Dec 20220247Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me